Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study

<p>Abstract</p> <p>Background</p> <p>Pneumococcal polysaccharide vaccine (PPV) is recommended for all adults 65 years of age and older and for younger adults with high-risk conditions. While data from national surveys provide information on the proportion of adults 65 y...

Full description

Bibliographic Details
Main Authors: Belongia Edward A, Naleway Allison L, Baxter Roger, Jackson Lisa A, Baggs James
Format: Article
Language:English
Published: BMC 2009-03-01
Series:BMC Infectious Diseases
Online Access:http://www.biomedcentral.com/1471-2334/9/37
id doaj-93c16dce102b46a185bf2586a82c0b3b
record_format Article
spelling doaj-93c16dce102b46a185bf2586a82c0b3b2020-11-25T03:42:49ZengBMCBMC Infectious Diseases1471-23342009-03-01913710.1186/1471-2334-9-37Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink studyBelongia Edward ANaleway Allison LBaxter RogerJackson Lisa ABaggs James<p>Abstract</p> <p>Background</p> <p>Pneumococcal polysaccharide vaccine (PPV) is recommended for all adults 65 years of age and older and for younger adults with high-risk conditions. While data from national surveys provide information on the proportion of adults 65 years of age and older reporting ever receipt of PPV they do not collect more detailed information, such as age at vaccination or the total number of vaccinations received. In addition, there is relatively little information available on PPV coverage in younger adults with chronic conditions. To assess contemporary patterns of pneumococcal vaccination and revaccination of adults, we conducted a cross-sectional study of adults enrolled in medical care organizations (MCOs) participating in the Vaccine Safety Datalink project.</p> <p>Methods</p> <p>The study population included 1.5 million adults 25 years of age and older enrolled in the four participating MCOs on December 1, 2006. PPVs administered to members of the study population prior to that date were identified from computerized immunization registries maintained by the MCOs.</p> <p>Results</p> <p>Among the general population of adults 25 through 64 years of age, vaccine coverage increased from 2% in the 25–29 year old age-group to 26% in the 60–64 year old age-group. In all age-groups, coverage was substantially higher in persons defined as having a chronic high risk condition. This was particularly true for diabetes mellitus, with vaccine coverage of over 50% in the lower age-groups and 75% in those 60–64 years of age. Among adults 65 years of age and older, 82% had received at least one PPV and 18% had received two or more PPVs.</p> <p>Conclusion</p> <p>We found higher levels of PPV coverage among adults 65 years of age and older and among younger adults with diabetes mellitus than reported by national surveys and for those groups PPV coverage approached the <it>Healthy People 2010 </it>national objectives. These results suggest that achieving those objectives for PPV is possible and that high vaccination coverage may be facilitated by vaccine tracking and reminder systems.</p> http://www.biomedcentral.com/1471-2334/9/37
collection DOAJ
language English
format Article
sources DOAJ
author Belongia Edward A
Naleway Allison L
Baxter Roger
Jackson Lisa A
Baggs James
spellingShingle Belongia Edward A
Naleway Allison L
Baxter Roger
Jackson Lisa A
Baggs James
Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study
BMC Infectious Diseases
author_facet Belongia Edward A
Naleway Allison L
Baxter Roger
Jackson Lisa A
Baggs James
author_sort Belongia Edward A
title Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study
title_short Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study
title_full Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study
title_fullStr Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study
title_full_unstemmed Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study
title_sort patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a vaccine safety datalink study
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2009-03-01
description <p>Abstract</p> <p>Background</p> <p>Pneumococcal polysaccharide vaccine (PPV) is recommended for all adults 65 years of age and older and for younger adults with high-risk conditions. While data from national surveys provide information on the proportion of adults 65 years of age and older reporting ever receipt of PPV they do not collect more detailed information, such as age at vaccination or the total number of vaccinations received. In addition, there is relatively little information available on PPV coverage in younger adults with chronic conditions. To assess contemporary patterns of pneumococcal vaccination and revaccination of adults, we conducted a cross-sectional study of adults enrolled in medical care organizations (MCOs) participating in the Vaccine Safety Datalink project.</p> <p>Methods</p> <p>The study population included 1.5 million adults 25 years of age and older enrolled in the four participating MCOs on December 1, 2006. PPVs administered to members of the study population prior to that date were identified from computerized immunization registries maintained by the MCOs.</p> <p>Results</p> <p>Among the general population of adults 25 through 64 years of age, vaccine coverage increased from 2% in the 25–29 year old age-group to 26% in the 60–64 year old age-group. In all age-groups, coverage was substantially higher in persons defined as having a chronic high risk condition. This was particularly true for diabetes mellitus, with vaccine coverage of over 50% in the lower age-groups and 75% in those 60–64 years of age. Among adults 65 years of age and older, 82% had received at least one PPV and 18% had received two or more PPVs.</p> <p>Conclusion</p> <p>We found higher levels of PPV coverage among adults 65 years of age and older and among younger adults with diabetes mellitus than reported by national surveys and for those groups PPV coverage approached the <it>Healthy People 2010 </it>national objectives. These results suggest that achieving those objectives for PPV is possible and that high vaccination coverage may be facilitated by vaccine tracking and reminder systems.</p>
url http://www.biomedcentral.com/1471-2334/9/37
work_keys_str_mv AT belongiaedwarda patternsofpneumococcalvaccinationandrevaccinationinelderlyandnonelderlyadultsavaccinesafetydatalinkstudy
AT nalewayallisonl patternsofpneumococcalvaccinationandrevaccinationinelderlyandnonelderlyadultsavaccinesafetydatalinkstudy
AT baxterroger patternsofpneumococcalvaccinationandrevaccinationinelderlyandnonelderlyadultsavaccinesafetydatalinkstudy
AT jacksonlisaa patternsofpneumococcalvaccinationandrevaccinationinelderlyandnonelderlyadultsavaccinesafetydatalinkstudy
AT baggsjames patternsofpneumococcalvaccinationandrevaccinationinelderlyandnonelderlyadultsavaccinesafetydatalinkstudy
_version_ 1724523386921549824